nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—CYP2C19—urine—bipolar disorder	0.0553	0.145	CbGeAlD
Gliclazide—CYP2C9—urine—bipolar disorder	0.0429	0.112	CbGeAlD
Gliclazide—VEGFA—adrenal cortex—bipolar disorder	0.0386	0.101	CbGeAlD
Gliclazide—CYP2C19—blood plasma—bipolar disorder	0.0289	0.0755	CbGeAlD
Gliclazide—VEGFA—thyroid gland—bipolar disorder	0.0269	0.0702	CbGeAlD
Gliclazide—CYP2C9—blood plasma—bipolar disorder	0.0224	0.0585	CbGeAlD
Gliclazide—VEGFA—cerebellum—bipolar disorder	0.0213	0.0556	CbGeAlD
Gliclazide—KCNJ11—thyroid gland—bipolar disorder	0.0192	0.0502	CbGeAlD
Gliclazide—ABCC8—thyroid gland—bipolar disorder	0.0177	0.0463	CbGeAlD
Gliclazide—VEGFA—brain—bipolar disorder	0.0173	0.0452	CbGeAlD
Gliclazide—KCNJ11—nervous system—bipolar disorder	0.0162	0.0423	CbGeAlD
Gliclazide—KCNJ11—cerebellum—bipolar disorder	0.0152	0.0398	CbGeAlD
Gliclazide—ABCC8—nervous system—bipolar disorder	0.0149	0.0389	CbGeAlD
Gliclazide—ABCC8—cerebellum—bipolar disorder	0.014	0.0366	CbGeAlD
Gliclazide—KCNJ11—brain—bipolar disorder	0.0124	0.0323	CbGeAlD
Gliclazide—ABCC8—brain—bipolar disorder	0.0114	0.0298	CbGeAlD
Gliclazide—ALB—brain—bipolar disorder	0.00815	0.0213	CbGeAlD
Gliclazide—ABCC8—Neuronal System—GRIN1—bipolar disorder	0.00361	0.00585	CbGpPWpGaD
Gliclazide—ABCC8—Regulation of insulin secretion—INS—bipolar disorder	0.00359	0.00581	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—GRIK2—bipolar disorder	0.00358	0.00579	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—GAD1—bipolar disorder	0.00354	0.00573	CbGpPWpGaD
Gliclazide—CYP2C19—Melatonin metabolism and effects—MAOA—bipolar disorder	0.0035	0.00567	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—GRIN1—bipolar disorder	0.0035	0.00567	CbGpPWpGaD
Gliclazide—KCNJ11—Regulation of insulin secretion—INS—bipolar disorder	0.00348	0.00563	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—GAD1—bipolar disorder	0.00343	0.00556	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—SERPINA1—bipolar disorder	0.00341	0.00551	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—CACNB2—bipolar disorder	0.00329	0.00533	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—CACNB2—bipolar disorder	0.00319	0.00516	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.00314	0.00508	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—GRIN1—bipolar disorder	0.00293	0.00474	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—DGKH—bipolar disorder	0.0029	0.00469	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00288	0.00466	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—TRPC3—bipolar disorder	0.00287	0.00464	CbGpPWpGaD
Gliclazide—ABCC8—Integration of energy metabolism—INS—bipolar disorder	0.00282	0.00457	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.00278	0.0045	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—NCAN—bipolar disorder	0.00276	0.00446	CbGpPWpGaD
Gliclazide—KCNJ11—Integration of energy metabolism—INS—bipolar disorder	0.00274	0.00443	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—SERPINA1—bipolar disorder	0.00271	0.00439	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—ANK3—bipolar disorder	0.0027	0.00437	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—CACNB2—bipolar disorder	0.00267	0.00432	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—SNAP25—bipolar disorder	0.00263	0.00426	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—bipolar disorder	0.00258	0.00418	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.00258	0.00418	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—SNAP25—bipolar disorder	0.00255	0.00413	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—IMPA2—bipolar disorder	0.00251	0.00407	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00251	0.00406	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00245	0.00397	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—CACNA1C—bipolar disorder	0.00244	0.00395	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—IMPA2—bipolar disorder	0.00244	0.00394	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IL1B—bipolar disorder	0.0024	0.00388	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—bipolar disorder	0.00238	0.00386	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—GRIN2B—bipolar disorder	0.00238	0.00385	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.00236	0.00382	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00235	0.0038	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—SLC6A3—bipolar disorder	0.00234	0.0038	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00233	0.00378	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—ADCY2—bipolar disorder	0.00233	0.00377	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—GRIN2B—bipolar disorder	0.00231	0.00373	CbGpPWpGaD
Gliclazide—CYP2C19—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.0023	0.00372	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—SLC6A3—bipolar disorder	0.00227	0.00368	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—ADCY2—bipolar disorder	0.00226	0.00365	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00213	0.00344	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—GRIN1—bipolar disorder	0.00209	0.00338	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TRPC3—bipolar disorder	0.00205	0.00331	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—MTHFR—bipolar disorder	0.00202	0.00328	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TRPC3—bipolar disorder	0.00201	0.00325	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—COMT—bipolar disorder	0.00199	0.00323	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—DGKH—bipolar disorder	0.00198	0.00321	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—MAOA—bipolar disorder	0.00198	0.0032	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—COMT—bipolar disorder	0.00193	0.00313	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—GRIN2B—bipolar disorder	0.00193	0.00312	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—MAOA—bipolar disorder	0.00192	0.00311	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CACNB2—bipolar disorder	0.0019	0.00308	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.0019	0.00308	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—INS—bipolar disorder	0.00181	0.00293	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—SERPINA1—bipolar disorder	0.00176	0.00284	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CACNA1C—bipolar disorder	0.00174	0.00282	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—IMPA1—bipolar disorder	0.0017	0.00275	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—MTHFR—bipolar disorder	0.00165	0.00266	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—IMPA1—bipolar disorder	0.00165	0.00266	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—GSK3B—bipolar disorder	0.00161	0.00261	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—INS—bipolar disorder	0.00161	0.0026	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.00159	0.00258	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00159	0.00257	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—GATA3—bipolar disorder	0.00149	0.00242	CbGpPWpGaD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00145	0.00234	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NDUFV2—bipolar disorder	0.00144	0.00234	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00141	0.00228	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NDUFV2—bipolar disorder	0.0014	0.00226	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKR1C4—bipolar disorder	0.0014	0.00226	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.00139	0.00225	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—GRIN2B—bipolar disorder	0.00138	0.00223	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TRPC3—bipolar disorder	0.00137	0.00223	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKR1C4—bipolar disorder	0.00135	0.00219	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—INS—bipolar disorder	0.00131	0.00212	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—MTHFR—bipolar disorder	0.00131	0.00212	CbGpPWpGaD
Gliclazide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00128	0.00206	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.00126	0.00204	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NR1D1—bipolar disorder	0.00125	0.00203	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00125	0.00203	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—GSK3B—bipolar disorder	0.00124	0.00201	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NR1D1—bipolar disorder	0.00122	0.00197	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SERPINA1—bipolar disorder	0.0012	0.00195	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL1B—bipolar disorder	0.0012	0.00194	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NCAN—bipolar disorder	0.0012	0.00194	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SLC5A3—bipolar disorder	0.00118	0.0019	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NCAN—bipolar disorder	0.00116	0.00188	CbGpPWpGaD
Gliclazide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00116	0.00188	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SLC5A3—bipolar disorder	0.00114	0.00185	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKR1C4—bipolar disorder	0.00107	0.00173	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—GSK3B—bipolar disorder	0.00105	0.0017	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—INS—bipolar disorder	0.00104	0.00168	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00103	0.00167	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—DGKH—bipolar disorder	0.00102	0.00166	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00101	0.00164	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DGKH—bipolar disorder	0.000982	0.00159	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL1B—bipolar disorder	0.000977	0.00158	CbGpPWpGaD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000943	0.00153	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000909	0.00147	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.000908	0.00147	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD5—bipolar disorder	0.000898	0.00145	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RGS4—bipolar disorder	0.000881	0.00143	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CLOCK—bipolar disorder	0.00085	0.00138	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—COMT—bipolar disorder	0.00085	0.00138	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—MAOA—bipolar disorder	0.000844	0.00137	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—COMT—bipolar disorder	0.000838	0.00136	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—TPH2—bipolar disorder	0.000828	0.00134	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—TSHB—bipolar disorder	0.000828	0.00134	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CACNB2—bipolar disorder	0.000828	0.00134	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.000828	0.00134	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CLOCK—bipolar disorder	0.000824	0.00133	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000816	0.00132	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—DPYD—bipolar disorder	0.000815	0.00132	CbGpPWpGaD
Gliclazide—ALB—Metabolism—IMPA2—bipolar disorder	0.00081	0.00131	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00081	0.00131	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—TSHB—bipolar disorder	0.000803	0.0013	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—TPH2—bipolar disorder	0.000803	0.0013	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CACNB2—bipolar disorder	0.000803	0.0013	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.0008	0.00129	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—DPYD—bipolar disorder	0.00079	0.00128	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL1B—bipolar disorder	0.000776	0.00126	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—COMT—bipolar disorder	0.000775	0.00125	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—MAOA—bipolar disorder	0.000769	0.00125	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—COMT—bipolar disorder	0.000764	0.00124	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CACNA1C—bipolar disorder	0.000758	0.00123	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—GSK3B—bipolar disorder	0.000751	0.00122	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000744	0.0012	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—INS—bipolar disorder	0.000741	0.0012	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PIK3C2A—bipolar disorder	0.000738	0.0012	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CACNA1C—bipolar disorder	0.000735	0.00119	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—IMPA2—bipolar disorder	0.000727	0.00118	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PIK3C2A—bipolar disorder	0.000716	0.00116	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TRPC3—bipolar disorder	0.000709	0.00115	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TRPC3—bipolar disorder	0.000681	0.0011	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—IMPA2—bipolar disorder	0.000663	0.00107	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SNAP25—bipolar disorder	0.000662	0.00107	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADM—bipolar disorder	0.000649	0.00105	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SNAP25—bipolar disorder	0.000642	0.00104	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PDE4B—bipolar disorder	0.000633	0.00102	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TSHB—bipolar disorder	0.000633	0.00102	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TACR1—bipolar disorder	0.000633	0.00102	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SERPINA1—bipolar disorder	0.000619	0.001	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000616	0.000996	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000613	0.000993	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ADCY2—bipolar disorder	0.000586	0.000949	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ADCY2—bipolar disorder	0.000568	0.00092	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000553	0.000895	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—POMC—bipolar disorder	0.000549	0.000889	CbGpPWpGaD
Gliclazide—ALB—Metabolism—IMPA1—bipolar disorder	0.000547	0.000886	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000535	0.000866	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—GATA3—bipolar disorder	0.000527	0.000853	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR1A—bipolar disorder	0.000524	0.000848	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TAC1—bipolar disorder	0.000516	0.000835	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR2C—bipolar disorder	0.000506	0.000819	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD1—bipolar disorder	0.000506	0.000819	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000504	0.000816	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—COMT—bipolar disorder	0.000502	0.000813	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—POMC—bipolar disorder	0.000501	0.000811	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MAOA—bipolar disorder	0.000498	0.000807	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NTRK2—bipolar disorder	0.000492	0.000797	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—IMPA1—bipolar disorder	0.000491	0.000795	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD3—bipolar disorder	0.00049	0.000793	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GSK3A—bipolar disorder	0.000488	0.00079	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—COMT—bipolar disorder	0.000487	0.000788	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MAOA—bipolar disorder	0.000483	0.000782	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.00048	0.000777	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD4—bipolar disorder	0.000476	0.00077	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NDUFV2—bipolar disorder	0.000465	0.000753	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKR1C4—bipolar disorder	0.00045	0.000729	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADCY2—bipolar disorder	0.000448	0.000725	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—IMPA1—bipolar disorder	0.000448	0.000725	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TCF7L2—bipolar disorder	0.000446	0.000722	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD2—bipolar disorder	0.000443	0.000717	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000438	0.000708	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NDUFV2—bipolar disorder	0.000418	0.000676	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000406	0.000658	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MTHFR—bipolar disorder	0.000406	0.000657	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NR1D1—bipolar disorder	0.000405	0.000655	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKR1C4—bipolar disorder	0.000404	0.000655	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000404	0.000653	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NTRK1—bipolar disorder	0.000401	0.00065	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MTHFR—bipolar disorder	0.000393	0.000637	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—S100B—bipolar disorder	0.00039	0.000631	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NCAN—bipolar disorder	0.000387	0.000627	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NDUFV2—bipolar disorder	0.000381	0.000616	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC5A3—bipolar disorder	0.000379	0.000614	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKR1C4—bipolar disorder	0.000369	0.000597	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NR1D1—bipolar disorder	0.000363	0.000588	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NCAN—bipolar disorder	0.000347	0.000562	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NRG1—bipolar disorder	0.000344	0.000557	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC5A3—bipolar disorder	0.00034	0.000551	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NR1D1—bipolar disorder	0.000331	0.000536	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—POMC—bipolar disorder	0.000324	0.000525	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—INS—bipolar disorder	0.000323	0.000522	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NCAN—bipolar disorder	0.000317	0.000513	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—POMC—bipolar disorder	0.000315	0.000509	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—INS—bipolar disorder	0.000313	0.000507	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HTR2A—bipolar disorder	0.00031	0.000503	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC5A3—bipolar disorder	0.00031	0.000502	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CLOCK—bipolar disorder	0.000274	0.000444	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TSHB—bipolar disorder	0.000267	0.000432	CbGpPWpGaD
Gliclazide—ALB—Metabolism—TPH2—bipolar disorder	0.000267	0.000432	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CACNB2—bipolar disorder	0.000267	0.000432	CbGpPWpGaD
Gliclazide—ALB—Metabolism—DPYD—bipolar disorder	0.000263	0.000425	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GSK3B—bipolar disorder	0.00025	0.000405	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—POMC—bipolar disorder	0.000248	0.000401	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INS—bipolar disorder	0.000247	0.000399	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CLOCK—bipolar disorder	0.000246	0.000398	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CACNA1C—bipolar disorder	0.000244	0.000396	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TSHB—bipolar disorder	0.00024	0.000388	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—TPH2—bipolar disorder	0.00024	0.000388	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CACNB2—bipolar disorder	0.00024	0.000388	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PIK3C2A—bipolar disorder	0.000238	0.000385	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—DPYD—bipolar disorder	0.000236	0.000382	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000235	0.00038	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CLOCK—bipolar disorder	0.000224	0.000363	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CACNA1C—bipolar disorder	0.000219	0.000355	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TPH2—bipolar disorder	0.000219	0.000354	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CACNB2—bipolar disorder	0.000219	0.000354	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—TSHB—bipolar disorder	0.000219	0.000354	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DPYD—bipolar disorder	0.000215	0.000348	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	0.000214	0.000346	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SNAP25—bipolar disorder	0.000214	0.000346	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000211	0.000341	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CACNA1C—bipolar disorder	0.0002	0.000324	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	0.000195	0.000316	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000192	0.000311	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SNAP25—bipolar disorder	0.000192	0.00031	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADCY2—bipolar disorder	0.000189	0.000306	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SNAP25—bipolar disorder	0.000175	0.000283	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADCY2—bipolar disorder	0.00017	0.000275	CbGpPWpGaD
Gliclazide—ALB—Metabolism—COMT—bipolar disorder	0.000162	0.000262	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MAOA—bipolar disorder	0.000161	0.00026	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADCY2—bipolar disorder	0.000155	0.00025	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—COMT—bipolar disorder	0.000145	0.000235	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MAOA—bipolar disorder	0.000144	0.000234	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—COMT—bipolar disorder	0.000132	0.000214	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MAOA—bipolar disorder	0.000132	0.000213	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—bipolar disorder	0.000131	0.000212	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—bipolar disorder	0.000117	0.00019	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—bipolar disorder	0.000107	0.000173	CbGpPWpGaD
Gliclazide—ALB—Metabolism—POMC—bipolar disorder	0.000105	0.000169	CbGpPWpGaD
Gliclazide—ALB—Metabolism—INS—bipolar disorder	0.000104	0.000168	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—POMC—bipolar disorder	9.39e-05	0.000152	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—INS—bipolar disorder	9.34e-05	0.000151	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—POMC—bipolar disorder	8.56e-05	0.000139	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—INS—bipolar disorder	8.52e-05	0.000138	CbGpPWpGaD
